Mirum Pharmaceuticals (MIRM) Asset Utilization Ratio (2021 - 2026)

Mirum Pharmaceuticals' Asset Utilization Ratio history runs 6 years deep, the most recent figure standing at 0.66 for Q1 2026.

• In Q1 2026, Asset Utilization Ratio rose 17.9% year-over-year to 0.66; the TTM figure through Mar 2026 stood at 0.66 (up 17.9% YoY), while the FY2025 annual figure was 0.69, up 34.69% from the prior year.
• Asset Utilization Ratio was 0.66 for Q1 2026 at Mirum Pharmaceuticals, up from 0.64 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.66 in Q1 2026 to a low of 0.11 in Q1 2022.
• Historically, Asset Utilization Ratio has averaged 0.39 across 5 years, with a median of 0.34 in 2024.
• The sharpest annual moves came in 2022 and 2026: Asset Utilization Ratio surged 197.44% in 2022, then climbed 17.9% in 2026.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.21 in 2022, then surged by 33.72% to 0.29 in 2023, then soared by 75.17% to 0.5 in 2024, then grew by 27.25% to 0.64 in 2025, then advanced by 2.6% to 0.66 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.66 (Q1 2026), 0.64 (Q4 2025), and 0.62 (Q3 2025), per Business Quant data.